Literature DB >> 29182490

Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.

Michael J Persky1, William G Albergotti2, Tanya J Rath3, Mark W Kubik2, Shira Abberbock4, Mathew Geltzeiler2, Seungwon Kim2, Umamaheswar Duvvuri2, Robert L Ferris2.   

Abstract

Objective To compare positive margin rates between the 2 most common subsites of oropharyngeal transoral robotic surgery (TORS), the base of tongue (BOT) and the tonsil, as well as identify preoperative imaging characteristics that predispose toward positive margins. Study Design Case series with chart review. Setting Tertiary care referral center. Subjects and Methods We compared the final and intraoperative positive margin rate between TORS resections for tonsil and BOT oropharyngeal squamous cell carcinoma (OPSCC), as well as the effect of margins on treatment. A blinded neuroradiologist examined the preoperative imaging of BOT tumors to measure their dimensions and patterns of spread and provided a prediction of final margin results. Results Between January 2010 and May 2016, a total of 254 patients underwent TORS for OPSCC. A total of 140 patients who underwent TORS for T1/T2 OPSCC met inclusion criteria. A final positive margin is significantly more likely for BOT tumors than tonsil tumors (19.6% vs 4.5%, respectively, P = .004) and likewise for intraoperative margins of BOT and tonsil tumors (35.3% vs 12.4%, respectively; P = .002). A positive final margin is 10 times more likely to receive chemoradiation compared to a negative margin, controlling for extracapsular spread and nodal status (odds ratio, 9.6; 95% confidence interval, 1.6-59.6; P = .02). Preoperative imaging characteristics and subjective radiologic examination of BOT tumors did not correlate with final margin status. Conclusion Positive margins are significantly more likely during TORS BOT resections compared to tonsil resections. More research is needed to help surgeons predict which T1/T2 tumors will be difficult to completely extirpate.

Entities:  

Keywords:  BOT resection; TORS; margin status; margins; oropharyngeal SCC; radical tonsillectomy

Mesh:

Year:  2017        PMID: 29182490      PMCID: PMC5880728          DOI: 10.1177/0194599817742852

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  20 in total

1.  Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.

Authors:  Garret W Choby; Jeehong Kim; Diane C Ling; Shira Abberbock; Rajarsi Mandal; Seungwon Kim; Robert L Ferris; Umamaheswar Duvvuri
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-06       Impact factor: 6.223

2.  Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.

Authors:  Benoit Morisod; Ioana I Venara-Vulpe; Stephen Alzuphar; Yan Monnier; Massimo Bongiovanni; Patric Hagmann; Hanan Bouchaab; Jean Bourhis; Christian Simon
Journal:  Head Neck       Date:  2017-02-11       Impact factor: 3.147

3.  Transoral robotic surgery for management of cervical unknown primary squamous cell carcinoma: Updates on efficacy, surgical technique and margin status.

Authors:  Mathew Geltzeiler; Sean Doerfler; Meghan Turner; William Greer Albergotti; Mark Kubik; Seungwon Kim; Robert Ferris; Umamaheswar Duvvuri
Journal:  Oral Oncol       Date:  2017-01-06       Impact factor: 5.337

Review 4.  Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.

Authors:  F Christopher Holsinger; Robert L Ferris
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

5.  Robotics in otolaryngology and head and neck surgery: Recommendations for training and credentialing: A report of the 2015 AHNS education committee, AAO-HNS robotic task force and AAO-HNS sleep disorders committee.

Authors:  Neil D Gross; F Christopher Holsinger; J Scott Magnuson; Umamaheswar Duvvuri; Eric M Genden; Tamer Ah Ghanem; Kathleen L Yaremchuk; David Goldenberg; Matthew C Miller; Eric J Moore; Luc Gt Morris; James Netterville; Gregory S Weinstein; Jeremy Richmon
Journal:  Head Neck       Date:  2016-03-07       Impact factor: 3.147

6.  Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.

Authors:  Jennifer R Cracchiolo; Shrujal S Baxi; Luc G Morris; Ian Ganly; Snehal G Patel; Marc A Cohen; Benjamin R Roman
Journal:  Cancer       Date:  2016-03-11       Impact factor: 6.860

7.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; William F Anderson; Maura L Gillison
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

8.  Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study.

Authors:  John R de Almeida; Ryan Li; J Scott Magnuson; Richard V Smith; Eric Moore; Georges Lawson; Marc Remacle; Ian Ganly; Dennis H Kraus; Marita S Teng; Brett A Miles; Hilliary White; Umamaheswar Duvvuri; Robert L Ferris; Vikas Mehta; Krista Kiyosaki; Edward J Damrose; Steven J Wang; Michael E Kupferman; Yoon Woo Koh; Eric M Genden; F Christopher Holsinger
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-12       Impact factor: 6.223

9.  Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.

Authors:  D C Ling; B V Chapman; J Kim; G W Choby; P Kabolizadeh; D A Clump; R L Ferris; S Kim; S Beriwal; D E Heron; U Duvvuri
Journal:  Oral Oncol       Date:  2016-08-25       Impact factor: 5.337

Review 10.  Functional outcomes after TORS for oropharyngeal cancer: a systematic review.

Authors:  Katherine A Hutcheson; F Christopher Holsinger; Michael E Kupferman; Jan S Lewin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-19       Impact factor: 2.503

View more
  4 in total

1.  Quantifying Tumor and Vasculature Deformations during Laryngoscopy.

Authors:  Xiaotian Wu; David A Pastel; Rihan Khan; Clifford J Eskey; Yuan Shi; Michael Sramek; Joseph A Paydarfar; Ryan J Halter
Journal:  Ann Biomed Eng       Date:  2022-01-07       Impact factor: 4.219

2.  Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.

Authors:  Jamie R Oliver; Michael J Persky; Binhuan Wang; Umamaheswar Duvvuri; Neil D Gross; Alec E Vaezi; Luc G T Morris; Babak Givi
Journal:  Cancer       Date:  2021-11-11       Impact factor: 6.921

Review 3.  Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma of the Tonsil versus Base of Tongue: A Systematic Review and Meta-Analysis.

Authors:  Nicolas S Poupore; Tiffany Chen; Shaun A Nguyen; Cherie-Ann O Nathan; Jason G Newman
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

4.  A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311.

Authors:  Robert L Ferris; Yael Flamand; F Christopher Holsinger; Gregory S Weinstein; Harry Quon; Ranee Mehra; Joaquin J Garcia; Michael L Hinni; Neil D Gross; Erich M Sturgis; Umamaheswar Duvvuri; Eduardo Méndez; John A Ridge; J Scott Magnuson; Kerry A Higgins; Mihir R Patel; Russel B Smith; Daniel W Karakla; Michael E Kupferman; James P Malone; Benjamin L Judson; Jeremy Richmon; Jay O Boyle; Rodrigo Bayon; Bert W O'Malley; Enver Ozer; Giovana R Thomas; Wayne M Koch; R Bryan Bell; Nabil F Saba; Shuli Li; Elin R Sigurdson; Barbara Burtness
Journal:  Oral Oncol       Date:  2020-07-14       Impact factor: 5.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.